| Accession |
PRJCA017207 |
| Title |
Infigratinib in Subjects with Gastric or gastroesophageal junction Cancer with FGFR2 Amplification or Other Solid Tumors with Other FGFR Genetic Alterations(LB1001-201 study) |
| Relevance |
Medical |
| Data types |
Data of Genomic Targeting Analysis and Statistics
|
| Organisms |
Homo sapiens
|
| Description |
A Phase IIa Multicenter, Open-Label, Single Arm Study of Oral Infigratinib in Subjects with Locally Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma with FGFR2 Genetic Amplification or Other Advanced Solid Tumors with Other FGFR Genetic Alterations |
| Sample scope |
Monoisolate |
| Release date |
2023-10-24 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Shanghai LianBio Development Co., Ltd.
|
|
N/A
|
|
|
|
| Submitter |
lin
shen (linshenpku@163.com)
|
| Organization |
Beijing Cancer Hospital |
| Submission date |
2023-05-24 |
